Skip to main content
Lifecare ASA logo

Lifecare ASA — Investor Relations & Filings

Ticker · LIFE ISIN · NO0013355859 LEI · 254900D88MYGZ7JD5P39 OL Manufacturing
Open in API
Filings indexed 812 across all filing types
Latest filing 2019-04-23 Regulatory Filings
Country NO Norway
Listing OL LIFE

About Lifecare ASA

https://lifecare.no/

Lifecare ASA is a clinical-stage medical sensor company specializing in the development of nanotechnology for medical applications. Its core activity involves creating miniaturized, implantable, and long-term nanobiosensors for the continuous monitoring of various body analytes. The company's primary focus is on developing a sensor for correct and continuous glucose monitoring to improve diabetes management. The business model is based on developing and licensing its proprietary sensor technology to facilitate the production and sale of advanced medical devices.

Recent filings

Filing Released Lang Actions
Lifecare Achieves Major Breakthrough in the Attempt to Miniaturize the Sencell Glucose Sensor
Regulatory Filings Classification · 95% confidence The document is a short announcement (1883 characters) from Lifecare AS dated April 23rd, 2019, detailing a 'Major Breakthrough' in their Sencell Glucose Sensor development concerning miniaturization achieved through a partnership with cantiMED. It describes scientific findings and quotes the Chairman of the Board. This content is a specific operational or technological update, not a formal financial report (like 10-K or IR), a management change (MANG), or a dividend notice (DIV). Since it is a specific announcement about a development milestone, it does not fit the defined categories like Earnings Release (ER) or Capital Update (CAP). Given the options, it is a general corporate announcement that doesn't fit the highly specific financial or regulatory categories. Therefore, the most appropriate fallback category is Regulatory Filings (RNS), as it is a general, non-financial, non-management specific announcement.
2019-04-23 English
Lifecare Achieves Major Breakthrough in the Attempt to Miniaturize the Sencell Glucose Sensor
Regulatory Filings Classification · 85% confidence The document text describes a significant technological breakthrough by Lifecare regarding the miniaturization of its Sencell Glucose Sensor, specifically involving a partnership with cantiMED to develop a smaller pressure transducer using nanosensor technology. This is an announcement about a scientific/product development milestone, not a formal financial filing like a 10-K, Earnings Release (ER), or Interim Report (IR). It does not fit the definitions for AGM-R, AR, MANG, CT, CAP, DVA, DLST, DIRS, SR, XLSX, FS, CGR, IRAT, IP, LTR, TAR, MRQ, MDA, NAV, DIV, PSI, RNS, DEF 14A, RPA, SHA, or POS. Since it is a specific operational/development update that doesn't fit the other categories, it is best classified as a general Regulatory Filing (RNS) as a fallback for significant, non-standard corporate news, although it is more akin to a press release about R&D progress.
2019-04-23 English
Lifecare AS - Share Option Program
Share Issue/Capital Change Classification · 95% confidence The document explicitly discusses the issuance of share options to management under an incentive program, detailing the number of options granted, the exercise price, vesting schedule, and the resulting holdings of primary insiders (executives). This directly relates to changes in the company's capital structure and employee equity plans. While it involves share issuance, the core focus is on the granting of options as part of compensation/incentive, which falls under Capital/Financing Update (CAP) or potentially Share Issue/Capital Change (SHA). However, since it details the mechanics of an option program authorized by a general meeting and involves executive grants, it is most accurately classified as a Capital/Financing Update (CAP) as it details a specific financing/equity mechanism being executed, or potentially a specific type of Share Issue/Capital Change (SHA). Given the context of incentive programs and option grants, CAP is a strong fit, but SHA covers share issuance directly. Since the document details the *grant* of options which leads to future share issuance, and it is a specific capital structure event, SHA is the most precise fit among the options provided for changes related to shares/capital structure, although CAP is also plausible. Reviewing the definitions, SHA is for 'new share issues, stock splits, or other capital changes.' Option grants are a form of capital change/share commitment. I will select SHA as the primary classification for changes in share capital structure via options.
2019-04-02 Norwegian
Lifecare AS - Share Option Program
Share Issue/Capital Change Classification · 95% confidence The document explicitly discusses the issuance of new shares (8,092,500) to management under a long-term incentive program, following approval from an Extraordinary General Meeting. This action directly relates to changes in the company's capital structure through the issuance of shares for employee incentives. This aligns best with the 'Share Issue/Capital Change' definition (SHA), which covers new share issues, rather than a general financing update (CAP) or insider trading report (DIRS). Given the small size and specific nature, SHA is the most precise fit.
2019-04-02 English
Lifecare AS - Aksjespleis og overføring aksjer styreformann 06.02.19
AGM Information Classification · 99% confidence The document is dated 11.02.19 and announces the execution of a reverse share split (aksjespleis) in an Extraordinary General Meeting (EGM) and a change in the shareholding of the Chairman of the Board. It details the mechanics of the 4:1 reverse split, the necessary amendment to the articles of association, and a related capital adjustment involving a major shareholder (Sterna Holding AS, owned by the Chairman). This action directly relates to the company's capital structure and financing activities, specifically addressing a requirement related to the minimum share price on the Merkur Market. This fits best under 'Capital/Financing Update' (CAP), as it describes a structural change to the share capital.
2019-02-12 Norwegian
Lifecare AS - Aksjespleis og overføring aksjer styreformann 06.02.19
Major Shareholding Notification Classification · 99% confidence The document text is very short (804 characters) and announces a corporate action involving a share split ('Aksjespleis') and a transfer of shares related to the Chairman of the Board ('styreformann'). Specifically, it details how Sterna Holding AS (owned by the Chairman) is transferring shares to facilitate the split so that all shareholders end up with a number of shares divisible by 4. This action directly relates to a change in the company's capital structure and share count. While it involves the Chairman, the primary focus is the share transaction/restructuring rather than just insider trading (DIRS) or a general management change (MANG). The most fitting category for changes in capital structure, share issues, or stock splits is 'Share Issue/Capital Change' (SHA).
2019-02-12 Norwegian

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.